Literature DB >> 21932314

Neurodevelopmental outcomes in children with Down syndrome and congenital heart defects.

Jeannie Visootsak1, William T Mahle, Paul M Kirshbom, Lillie Huddleston, Marcia Caron-Besch, Amy Ransom, Stephanie L Sherman.   

Abstract

Trisomy 21, the chromosomal condition responsible for Down syndrome (DS, OMIM #190685), is the most common identifiable genetic cause of intellectual disability. Approximately half of all children with DS are born with a significant congenital heart defect (CHD), the most common of which is an atrioventricular septal defect (AVSD). As children with comorbid DS and CHD increasingly survive cardiac surgery, characterization of their early developmental trajectories is critical for designing early interventions to maximize individual potential. Herein, the developmental domains (cognitive, language, and motor) of children with DS and AVSD (DS + AVSD, n = 12) were compared to children with DS and a structurally normal heart (DS - CHD, n = 17) using the Bayley Scales of Infant and Toddler Development III. The DS + AVSD cohort mean age was relatively the same as controls with DS - CHD, 14.5 ± 7.3 months compared with 14.1 ± 8.4 months, respectively. Although the motor domain was the only domain that showed a statistically significant difference between groups (P < 0.05), both cognitive standard scores (P = 0.63) and language composite standard scores (P = 0.10) were lower in the DS + AVSD cases compared with the DS - CHD controls although it is not statistically significant. Since this is the first study to examine the early developmental outcomes of children with DS + AVSD, the findings may be useful for clinicians in providing anticipatory guidance.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21932314      PMCID: PMC3200497          DOI: 10.1002/ajmg.a.34252

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  22 in total

Review 1.  Down syndrome: progress in research.

Authors:  N J Roizen
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2001

2.  A ten year review of atrioventricular septal defects.

Authors:  Kathryn A Dunlop; H Connor Mulholland; Frank A Casey; Brian Craig; Dennis J Gladstone
Journal:  Cardiol Young       Date:  2004-02       Impact factor: 1.093

3.  Linkage disequilibrium mapping in trisomic populations: analytical approaches and an application to congenital heart defects in Down syndrome.

Authors:  Kimberly F Kerstann; Eleanor Feingold; Sallie B Freeman; Lora J H Bean; Robert Pyatt; Stuart Tinker; Amy H Jewel; George Capone; Stephanie L Sherman
Journal:  Genet Epidemiol       Date:  2004-11       Impact factor: 2.135

4.  Updated National Birth Prevalence estimates for selected birth defects in the United States, 2004-2006.

Authors:  Samantha E Parker; Cara T Mai; Mark A Canfield; Russel Rickard; Ying Wang; Robert E Meyer; Patrick Anderson; Craig A Mason; Julianne S Collins; Russell S Kirby; Adolfo Correa
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2010-09-28

Review 5.  Long-term developmental outcome of children with complex congenital heart disease.

Authors:  W T Mahle; G Wernovsky
Journal:  Clin Perinatol       Date:  2001-03       Impact factor: 3.430

Review 6.  Behavioral phenotype of individuals with Down syndrome.

Authors:  R S Chapman; L J Hesketh
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2000

7.  Long-term follow-up of children with Down syndrome with cardiac lesions.

Authors:  P Mathew; D Moodie; R Sterba; D Murphy; E Rosenkranz; A Homa
Journal:  Clin Pediatr (Phila)       Date:  1990-10       Impact factor: 1.168

8.  Apolipoprotein E genotype and neurodevelopmental sequelae of infant cardiac surgery.

Authors:  J William Gaynor; Marsha Gerdes; Elaine H Zackai; Judy Bernbaum; Gil Wernovsky; Robert R Clancy; Mark F Newman; Ann M Saunders; Patrick J Heagerty; Jo Ann D'Agostino; Donna McDonald-McGinn; Susan C Nicolson; Thomas L Spray; Gail P Jarvik
Journal:  J Thorac Cardiovasc Surg       Date:  2003-12       Impact factor: 5.209

9.  Neurodevelopmental status at eight years in children with dextro-transposition of the great arteries: the Boston Circulatory Arrest Trial.

Authors:  David C Bellinger; David Wypij; Adre J duPlessis; Leonard A Rappaport; Richard A Jonas; Gil Wernovsky; Jane W Newburger
Journal:  J Thorac Cardiovasc Surg       Date:  2003-11       Impact factor: 5.209

10.  Congenital cardiovascular malformations associated with chromosome abnormalities: an epidemiologic study.

Authors:  C Ferencz; C A Neill; J A Boughman; J D Rubin; J I Brenner; L W Perry
Journal:  J Pediatr       Date:  1989-01       Impact factor: 4.406

View more
  18 in total

Review 1.  Joint attention in Down syndrome: A meta-analysis.

Authors:  Laura J Hahn; Susan J Loveall; Madison T Savoy; Allie M Neumann; Toshikazu Ikuta
Journal:  Res Dev Disabil       Date:  2018-05-21

Review 2.  Recent advances in our understanding of neurodevelopmental outcomes in congenital heart disease.

Authors:  Brian R White; Lindsay S Rogers; Matthew P Kirschen
Journal:  Curr Opin Pediatr       Date:  2019-12       Impact factor: 2.856

3.  Influence of CHDs on psycho-social and neurodevelopmental outcomes in children with Down syndrome.

Authors:  Jeannie Visootsak; Lillie Huddleston; Allison Buterbaugh; Adrienne Perkins; Stephanie Sherman; Jessica Hunter
Journal:  Cardiol Young       Date:  2015-02-16       Impact factor: 1.093

4.  Associations Between Medical History, Cognition, and Behavior in Youth With Down Syndrome: A Report From the Down Syndrome Cognition Project.

Authors:  Tracie C Rosser; Jamie O Edgin; George T Capone; Debra R Hamilton; Emily G Allen; Kenneth J Dooley; Payal Anand; John F Strang; A Chelsea Armour; Michelle A Frank-Crawford; Marie Moore Channell; Elizabeth I Pierpont; Eleanor Feingold; Cheryl L Maslen; Roger H Reeves; Stephanie L Sherman
Journal:  Am J Intellect Dev Disabil       Date:  2018-11

5.  Effect of congenital heart defects on language development in toddlers with Down syndrome.

Authors:  J Visootsak; B Hess; R Bakeman; L B Adamson
Journal:  J Intellect Disabil Res       Date:  2012-09-24

6.  Risk and prevalence of developmental delay in young children with congenital heart disease.

Authors:  Kathleen A Mussatto; Raymond G Hoffmann; George M Hoffman; James S Tweddell; Laurel Bear; Yumei Cao; Cheryl Brosig
Journal:  Pediatrics       Date:  2014-02-02       Impact factor: 7.124

7.  Changing Paradigms in Down Syndrome: The First International Conference of the Trisomy 21 Research Society.

Authors:  Jean-Maurice Delabar; Bernadette Allinquant; Diana Bianchi; Tom Blumenthal; Alain Dekker; Jamie Edgin; John O'Bryan; Mara Dierssen; Marie-Claude Potier; Frances Wiseman; Faycal Guedj; Nicole Créau; Roger Reeves; Katheleen Gardiner; Jorge Busciglio
Journal:  Mol Syndromol       Date:  2016-09-16

8.  Outcome Measures for Clinical Trials in Down Syndrome.

Authors:  Anna J Esbensen; Stephen R Hooper; Deborah Fidler; Sigan L Hartley; Jamie Edgin; Xavier Liogier d'Ardhuy; George Capone; Frances A Conners; Carolyn B Mervis; Leonard Abbeduto; Michael Rafii; Sharon J Krinsky-McHale; Tiina Urv
Journal:  Am J Intellect Dev Disabil       Date:  2017-05

9.  Considerations for measuring individual outcomes across contexts in Down syndrome: Implications for research and clinical trials.

Authors:  Anna J Esbensen; Emily K Schworer; Deborah J Fidler; Angela John Thurman
Journal:  Int Rev Res Dev Disabil       Date:  2022-08-19

Review 10.  Supporting Optimal Neurodevelopmental Outcomes in Infants and Children With Congenital Heart Disease.

Authors:  Jennifer K Peterson
Journal:  Crit Care Nurse       Date:  2018-06       Impact factor: 1.708

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.